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Variable Hazard ratio [95%
CI]
P value
Age (per 10 year increase) 1.58 [1.30, 1.91] <0.0001
History of diabetes mellitus 1.82 [1.27, 2.62] 0.001
History of peripheral vascular disease 1.83 [1.09, 3.07] 0.02
History of smoking 1.50 [1.05, 2.14] 0.03
History of prior myocardial infarction 1.82 [1.21, 2.72] 0.004
Baseline creatinine clearance <60 2.03 [1.35, 3.07] 0.001
Killip class 1 (vs. 2-4) 0.41 [0.28, 0.61] <0.0001
LAD infarct artery (vs. all others) 1.75 [1.13, 2.70] 0.01
Door to balloon (or ﬁrst device) (per
hour)
1.09 [0.92, 1.29] 0.32
Final TIMI 3 ﬂow (vs. 0-2) 0.49 [0.34, 0.72] <0.0001
Any IAE 1.83 [1.04, 3.21] 0.04
Demographic features and clinical outcomes in Non transfer STEMI Vs
Transfer STEMI groups
Variable Non Transfer STEMI
(n¼501)
Transfer STEMI
(n¼507)
P value
Age 62 +/- 13 60 +/- 13 0.07
Males 75% 71% 0.17
Diabetes Mellitus 21% 21% 0.8
Mean Ejection fraction 47 +/- 11 47 +/- 10 0.9
Cardiogenic shock and/or cardiac
arrest before PCI
12.8% 14.4% 0.45
Cardiogenic shock after PCI 2.8% 4.2% 0.24
CHF after PCI 2.2% 2.4% 0.85
IABP use 7.6% 7.3% 0.8
Stroke after PCI 1.2% 0.6% 0.3
Goal DTB time achieved 85% (<90 min) 33% (<120 min) <0.001
In hospital mortality 5.2% 5.3% 0.9
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transferred for primary PCI from non PCI facility enable these patients to have similar
short term clinical outcomes as patients presenting directly to PCI facility.
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Background: Ischemic post-conditioning (IPoC) is believed to improve the outcome
in ST elevation myocardial infarction (STEMI) undergoing primary percutaneous
intervention (PPCI) by minimizing the reperfusion injury though several trials have
shown variable results. We sought to perform a meta-analysis of randomized
controlled trials (RCTs) comparing IPoC versus standard therapy during PPCI.
Methods: PubMed, Cochrane and Web of Science databases were searched through
April 30th 2014 for RCTs comparing IPoC versus standard therapy during PPCI.
Outcomes analyzed were infract size by MRI (% of LV mass), peak cardiac bio-
markers(troponins), left ventricle ejection fraction(LVEF) by MRI & transthoracic
echo(TTE), ST segment resolution of  70% (ST70), death, myocardial infarc-
tion(MI) and subsequent revascularization. Study quality, publication bias, heteroge-
neity were assessed. Random effect model used for data analysis.
Results: 26 RCTs with 2330 patients (IPoC 1169, Control 1161) were included for the
analysis. Infarct size assessed by MRI (SMD -0.06 (p¼0.84) at 1 wk, -0.03 (p¼0.88)
at 1-6 mo), peak troponin (SMD 0.04 p¼0.91), ST70 (RR 1.04 p¼0.78) and LVEF
both by MRI (SMD 0.14 (p¼0.12) at 1wk, 0.04 (p¼0.7) at 1-6 mo) & TTE (SMD
0.28 (p¼0.1) at 1wk, 0.11 (p¼0.57) at 1-6 mo, 1.18(p¼0.06) at 1-3 yr) were similar in
both groups (IPoC versus control). Similarly there was no difference in clinical
endpoints like death (RR 1.44 p¼0.28), MI (RR 1.83 p¼0.37) and subsequent
revascularization (RR 1.2 p¼0.75).
Conclusions: IPoC compared to standard therapy is neither associated with any
signiﬁcant beneﬁt in terms of clinical outcomes nor improvement in degree of
myocardial necrosis in STEMI patients undergoing PPCI.
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Background: There is very little clinical data or speciﬁc management guidelines for
very elderly patients with ST Elevation MI (STEMI). We evaluated our practice in the
management of STEMI in patients over age 85.
Methods: A retrospective study of STEMI patients aged >85 in a PPCI (Primary
percutaneous coronary intervention) centre in the UK between April 2012-November
2013. Data was collected from Intellect, MINAP databases and discharge documents.
Results: Of the 993 patients with STEMI, 66 (6.6%) were > 85 years of age. There
were 38 males and 28 females (average age 88 (85-96) years). 35(63%) had PPCI and
31 (27%) treated medically. Inferior MI (50%) was more common than Anterior
(36%). Patients had multiple co-morbidities: Hypertension (32), smoking history (30),
Ischaemic Heart Disease (11), Hyperlipidaemia (8), Diabetes Mellitus (7) and Stroke
(6). 77% (51) were discharged alive and 23 % (11) died in hospital and a further 16%
(11) died 1 year post-discharge. In –hospital complication rate was 13 %( 8). Of 31
managed conservatively, 21 (67%) were females. Average age 89 years with multiple
co-morbidities. Presentation included dizziness, abdominal pain, feeling unwell,
vomiting and collapse. PPCI was not offered due to late presentation (>12 hours afterB14 JACC Vol 64/11/Suppl B jsymptom onset) (32%), poor prognosis, cardiogenic shock, high risk of bleeding,
resolution of symptoms and ECG and frailty. 20 (64%) were discharged alive, 7(22%)
died in the hospital and 4 transferred to a different hospital. Additional 8 (25%) died 1
year post-discharge. Complication rate was 12%. In the PPCI group (35), 24 (68%)
male patients, average age 87 years presented with typical symptoms and multiple co-
morbidities. 30(85%) of patients were discharged alive and a further (3)8.5% died
within 1 year post-discharge. Complication rate was 14%.
Conclusions: Elderly patients undergoing PPCI had better outcomes. Both groups had
multiple co-morbidities. Overall complication rate was 13%; although PPCI group had
a higher complication rate but a lower mortality 1 year post-discharge. Therefore,
PPCI has a role in treating the very elderly with STEMI, this analysis emphasises the
need for clinical trials targeted at this population.
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Background: Rapid reperfusion with primary percutaneous coronary intervention
(PCI) improves survival in patients with ST-segment elevation myocardial infarction
(STEMI). Pre-procedural cardiopulmonary instability and adverse events (IAE) may
delay reperfusion time and worsen prognosis. We set out to evaluate the relationship
between pre-procedural cardiopulmonary instability and adverse events (IAE), door-
to-balloon time (DBT), and outcomes in the HORIZONS-AMI trial.
Methods: Pre-procedural cardiopulmonary IAE included sustained ventricular or
supraventricular tachycardia or ﬁbrillation requiring cardioversion or deﬁbrillation,
heart block or bradycardia requiring pacemaker implantation, severe hypotension
requiring vasopressors or intraaortic balloon counterpulsation, respiratory failure
requiring mechanical ventilation, and cardiopulmonary resuscitation. We compared
3-year outcomes of patients with and without IAE according to DBT.
Results: Among 3,602 patients, 159 (4.4%) had at least one IAE. DBT did not differ
signiﬁcantly in patients with and without IAE; however, patients with IAE were less
likely to have TIMI 3 ﬂow after PCI. Mortality at 3 years was signiﬁcantly higher in
patients with vs. without IAE (17.0% vs. 6.3%, P< 0.0001), and IAE was an inde-
pendent predictor of mortality (see Table), whereas DBT was not. However, a sig-
niﬁcant interaction was present such that 3-year mortality was reduced in patients with
DBT < 99 minutes (the median) vs. 99 minutes to a greater extent in patients with
IAE (9.9% vs. 20.7%, HR[95%CI] ¼ 0.43 [0.16,1.16]) compared to those without
IAE (5.0% vs. 7.2%, HR ¼ 0.69 [0.50,0.95], Pinteraction¼0.004).
Conclusions: IAE prior to PCI is an independent predictor of death and identiﬁes a
high-risk group in whom faster reperfusion may be particularly important to improve
survival.TCT-48
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Background: No consensus exists about which coronary artery should be ﬁrstly
catheterized in primary PCIs. Initial catheterization of the “culprit artery” (supposed
by ECG) could reduce reperfusion time. However, knowledge of multivessel diseaseSeptember 13–17, 2014 j TCT Abstracts/Acute Myocardial Infarction
